{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:21:20Z","timestamp":1789521680472,"version":"build-2803163510"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Health Research, Ministry of Health and Family Welfare, Government of India","award":["V.25011\/570(i)\/2010-HR Dt.07.01.2014"],"award-info":[{"award-number":["V.25011\/570(i)\/2010-HR Dt.07.01.2014"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Sickle cell diseases (SCD) are the most common genetic disorders with significant morbidity and mortality worldwide, including in India. The high prevalence of this disorder in many geographical regions calls for the use of a point-of-care rapid diagnostic test (RDT) for early screening and management of the diagnosed cases to reduce the allied clinical severity. In view of this, the present study was undertaken for the validation of a point-of-care RDT kit (SICKLECHECK<jats:sup>TM<\/jats:sup>) for the screening of SCD. This validation and diagnostic accuracy study was conducted among the cases advised for screening of SCD. For validation, all the recruited cases were investigated for both the SICKLECHECK<jats:sup>TM<\/jats:sup> RDT kit and HPLC (Variant-II) considering HPLC as a gold standard. A total of 400 cases were screened for both tests. For the presence and absence of sickle cell hemoglobin in the samples, SICKLECHECK<jats:sup>TM<\/jats:sup> RDT kit results showed a sensitivity and specificity of 99.39% and 98.73% respectively with references to HPLC findings. For the detection of the \u2018AS\u2019 pattern, the SICKLECHECK<jats:sup>TM<\/jats:sup> RDT kit has shown a sensitivity and specificity of 99.07% and 98.81% respectively. For the detection of the \u2018SS\u2019 pattern, the SICKLECHECK<jats:sup>TM<\/jats:sup> RDT kit has shown a sensitivity and specificity of 97.92% and 100.0% respectively. Cases with \u03b2 thalassemia trait, hemoglobin E trait, hemoglobin Lepore trait and trait for hereditary-persistence-of-fetal-hemoglobin (high HbF %) diagnosed in HPLC were resulted with \u2018AA\u2019 pattern in SICKLECHECK<jats:sup>TM<\/jats:sup> RDT kit. The high sensitivity and specificity of the SICKLECHECK<jats:sup>TM<\/jats:sup> RDT kit insist on its use as a point-of-care screening tool for SCD especially where there is a lack of laboratory facilities as well as in hospital-based set-up requiring immediate diagnosis and management of SCD. However, for further confirmation, the samples should be analyzed with other gold standard techniques like HPLC.<\/jats:p>","DOI":"10.1371\/journal.pone.0309045","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T17:40:14Z","timestamp":1723830014000},"page":"e0309045","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of a point-of-care rapid diagnostic test kit (SICKLECHECK) for screening of sickle cell diseases"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5048-3977","authenticated-orcid":true,"given":"Prasanta","family":"Purohit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmayee","family":"Parida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan Kumar","family":"Martha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Bholo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparupa","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3518-0019","authenticated-orcid":true,"given":"Samira Kumar","family":"Behera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"issue":"2","key":"pone.0309045.ref001","doi-asserted-by":"crossref","first-page":"021103","DOI":"10.7189\/jogh.08.021103","article-title":"The global burden of sickle cell disease in children under five years of age: a systematic review and meta-analysis","volume":"8","author":"E Wastnedge","year":"2018","journal-title":"J Glob Health"},{"key":"pone.0309045.ref002","doi-asserted-by":"crossref","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010\u20132050:modelling based on demographics, excess mortality, and interventions.","volume":"10","author":"FB Piel","year":"2013","journal-title":"PLoS Med"},{"key":"pone.0309045.ref003","doi-asserted-by":"crossref","first-page":"17685","DOI":"10.1038\/s41598-018-36077-w","article-title":"The spatial epidemiology of sickle cell anemia","volume":"8","author":"C Hockham","year":"2018","journal-title":"India. Sci Rep"},{"issue":"4","key":"pone.0309045.ref004","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/03630269.2014.931287","article-title":"Prevalence of the \u03b2(S) gene among scheduled castes, scheduled tribes and other backward class groups in Central India.","volume":"38","author":"AV Shrikhande","year":"2014","journal-title":"Hemoglobin"},{"key":"pone.0309045.ref005","first-page":"509","article-title":"Sickle cell disease in tribal populations in India","volume":"141","author":"RB Colah","year":"2015","journal-title":"Indian J Med Res"},{"issue":"R1","key":"pone.0309045.ref006","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1093\/hmg\/ddab004","article-title":"Evolutionary history of sickle-cell mutation: implications for global genetic medicine","volume":"30","author":"K Esoh","year":"2021","journal-title":"Hum Mol Genet"},{"key":"pone.0309045.ref007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-3233(08)60287-9","article-title":"Sickle cell haemoglobin polymerization","volume":"40","author":"WA Eaton","year":"1990","journal-title":"Adv Protein Chem"},{"key":"pone.0309045.ref008","doi-asserted-by":"crossref","first-page":"193252","DOI":"10.1155\/2013\/193252","article-title":"Sickle cell disease: new opportunities and challenges","volume":"2013","author":"J Makani","year":"2013","journal-title":"Africa. Scientific World Journal"},{"issue":"3","key":"pone.0309045.ref009","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2257.1997.tb00002.x","article-title":"The use of automated HPLC to detect and quantitate haemoglobins.","volume":"19","author":"B Wild","year":"1997","journal-title":"Clinical & Laboratory Haematology"},{"key":"pone.0309045.ref010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0009-8981(99)00167-9","article-title":"Capillary isoelectric focusing of haemoglobin variants in the clinical laboratory","volume":"289","author":"MA Jenkins","year":"1999","journal-title":"Clin Chim Acta"},{"key":"pone.0309045.ref011","first-page":"46","article-title":"Laboratory investigation of hemoglobinopathies and thalassemias: review and update","author":"GM Clarke","year":"2000","journal-title":"Clin Chem"},{"key":"pone.0309045.ref012","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cca.2019.10.025","article-title":"Emerging point-of-care technologies for sickle cell disease diagnostics","volume":"501","author":"S Ilyas","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"1","key":"pone.0309045.ref013","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1097\/j.pbj.0000000000000126","article-title":"Incidence of hemoglobin disorders in southern Odisha, India: A hospital based study.","volume":"6","author":"P Sahu","year":"2021","journal-title":"Porto Biomed J"},{"key":"pone.0309045.ref014","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jbi.2014.02.013","article-title":"Sample size estimation in diagnostic test studies of biomedical informatics.","volume":"48","author":"K. Hajian-Tilaki","year":"2014","journal-title":"J Biomed Inform"},{"issue":"2","key":"pone.0309045.ref015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/tmi.12428","article-title":"Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality","volume":"20","author":"J Makani","year":"2015","journal-title":"Trop Med Int Health"},{"issue":"6","key":"pone.0309045.ref016","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/pbc.25391","article-title":"Low and fixed dose of hydroxyurea is effective and safe in patients with HbS\u03b2+ thalassemia with IVS1-5(G\u2192C) mutation.","volume":"62","author":"S Dehury","year":"2015","journal-title":"Pediatric Blood Cancer"},{"key":"pone.0309045.ref017","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12916-015-0473-6","article-title":"Validation of a novel point of care testing device for sickle cell disease","volume":"13","author":"J Kanter","year":"2015","journal-title":"BMC Med"},{"issue":"4","key":"pone.0309045.ref018","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/bjh.14298","article-title":"A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies","volume":"175","author":"CT Quinn","year":"2016","journal-title":"Br J Haematol"},{"key":"pone.0309045.ref019","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0022-1759(92)90104-2","article-title":"Studies of the \u201chook\u201d effect in the one-step sandwich immunoassay.","volume":"151","author":"SA Fernando","year":"1992","journal-title":"J Immunol Methods"},{"issue":"5","key":"pone.0309045.ref020","doi-asserted-by":"crossref","first-page":"e0177732","DOI":"10.1371\/journal.pone.0177732","article-title":"Towards a point-of-care strip test to diagnose sickle cell anemia","volume":"12","author":"M Bond","year":"2017","journal-title":"PLoS ONE"},{"key":"pone.0309045.ref021","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajh.25305","article-title":"Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test","volume":"94","author":"C Steele","year":"2019","journal-title":"Am J Hematol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0309045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T17:40:40Z","timestamp":1723830040000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0309045"}},"subtitle":[],"editor":[{"given":"Ibrahim Sebutu","family":"Bello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0309045","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]}}}